Profile
Eugene H.
Cordes served as Chairman at Vitae Pharmaceuticals LLC from 2002 to 2006.
He was also a Director at Vertex Pharmaceuticals, Inc. from 2005 to 2011, and a Director at Millennium Pharmaceuticals, Inc. and BioLeap, Inc. He is currently a Professor at the University of Michigan.
Cordes earned his doctorate from Brandeis University in 1962 and his undergraduate degree from the California Institute of Technology in 1958.
Former positions of Eugene H. Cordes
| Companies | Position | End |
|---|---|---|
| VITAE PHARMACEUTICALS INC | Chairman | 2006-02-28 |
BioLeap, Inc.
 BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Director/Board Member | - |
| University of Michigan | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Director/Board Member | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Training of Eugene H. Cordes
| Brandeis University | Doctorate Degree |
| California Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
BioLeap, Inc.
BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Health Technology |
- Stock Market
- Insiders
- Eugene H. Cordes
